InsidersTradesSigma
Track the Allugator Bioscience stock price and the full management transaction log of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Allugator Bioscience has logged 0 reports. Market capitalisation: €22.8m. All data is accessible without an account.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Declarations0 total
No declarations found
0 of 0 declarations
About Allugator Bioscience
Allugator Bioscience is a company focused on developing innovative therapies for cancer treatment. It specializes in creating antibody-based drugs to target tumor cells.